Ivospemin
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Ivospemin
- DrugBank Accession Number
- DB17988
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 318.506
Monoisotopic: 318.29947648 - Chemical Formula
- C16H38N4O2
- Synonyms
- (6S,15S)-3,8,13,18-Tetraazaeicosane-6,15-diol
- (6S,15S)-3,8,13,18-Tetraazaicosane-6,15-diol
- 3,8,13,18-tetraazaeicosane-6,15-diol, (6s,15s)-
- External IDs
- SBP-101
- SUN-101
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Ivospemin tetrahydrochloride 2RKV12BBA7 259657-09-5 SCDBHUCANIJZED-VNMXSFETSA-N
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 775S1NC70I
- CAS number
- 748119-79-1
- InChI Key
- AFXLPCNTPZQBIC-HOTGVXAUSA-N
- InChI
- InChI=1S/C16H38N4O2/c1-3-17-11-7-15(21)13-19-9-5-6-10-20-14-16(22)8-12-18-4-2/h15-22H,3-14H2,1-2H3/t15-,16-/m0/s1
- IUPAC Name
- (6S,15S)-3,8,13,18-tetraazaicosane-6,15-diol
- SMILES
- CCNCC[C@H](O)CNCCCCNC[C@@H](O)CCNCC
References
- General References
- Not Available
- External Links
- ChemSpider
- 8059176
- ChEMBL
- CHEMBL80386
- ZINC
- ZINC000003982713
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Completed Treatment Chronic Obstructive Pulmonary Disease (COPD) 3 2, 3 Recruiting Treatment Pancreatic Ductal Adenocarcinoma (PDAC) / Pancreatic Metastatic Cancer / Stage IV Pancreatic Cancer 1 1 Completed Treatment Pancreatic Cancer / Pancreatic Ductal Adenocarcinoma (PDAC) 1 1 Completed Treatment Pancreatic Metastatic Cancer / Stage IV Pancreatic Cancer 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -1.1 Chemaxon pKa (Strongest Acidic) 14.56 Chemaxon pKa (Strongest Basic) 10.73 Chemaxon Physiological Charge 4 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 6 Chemaxon Polar Surface Area 88.58 Å2 Chemaxon Rotatable Bond Count 17 Chemaxon Refractivity 93.53 m3·mol-1 Chemaxon Polarizability 40.33 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 17, 2023 17:40 / Updated at September 28, 2023 05:47